Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Paclitaxel or CT-2103 in Ovarian Cancer
NCT00108745Phase 3Unknown
- Sponsor
- GOG Foundation
- Start
- Mar 2005
- Primary completion
- Feb 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel poliglumex in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by GOG Foundation. Status: unknown.
02
Drugs
paclitaxel poliglumex
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00108745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108745.